Türkiye–U.S. M&A Daily Brief — September 9, 2026
Point72 acquires HubX in a Turkish fintech cross-border deal; U.S. closings include S&P Global–DataCenterHawk and Warburg Pincus–PantherX Rare.
As of 8:00 a.m. EDT / 3:00 p.m. Türkiye time on September 9, 2026. This brief reviews developments from September 8 through September 9.
Point72 Ventures acquires HubX — Turkish fintech cross-border deal
Point72 Ventures, the venture capital arm of Steve Cohen's Point72 Asset Management, signed a definitive agreement on September 8 to acquire HubX, an Istanbul-based B2B financial data and workflow automation platform serving corporate treasury and finance teams. The transaction value was not disclosed. HubX's platform integrates with ERP systems and banking APIs to automate cash management, payment reconciliation, and financial reporting workflows for mid-market and enterprise clients across Türkiye and the broader MENA region.
This is a meaningful Turkish-origin technology acquisition by a U.S. financial services investor. The deal structure raises several cross-border considerations. HubX's banking API integrations and data-handling practices will require review under Turkish data protection law (KVKK) and any applicable Central Bank of Türkiye regulations governing financial data intermediaries. If HubX processes payment data, the scope of its payment institution license and any passporting arrangements into other MENA jurisdictions must be confirmed before the transaction closes. On the U.S. side, Point72 Ventures' acquisition of a financial data platform may attract CFIUS attention if HubX's data includes sensitive financial information about U.S. persons or entities, even if the target is not U.S.-based. Counsel should assess whether a voluntary CFIUS filing is appropriate given the data profile.
Post-closing, the integration of HubX's Turkish engineering team into a U.S.-managed portfolio company structure will require attention to Turkish employment law, particularly the rules governing collective redundancy, non-compete enforceability, and equity incentive plan design for Turkish employees.
S&P Global completes DataCenterHawk acquisition
S&P Global completed its acquisition of DataCenterHawk, a data center market intelligence and analytics platform, on September 8. DataCenterHawk provides real-time data on data center capacity, availability, pricing, and development pipelines across North America, Europe, and Asia-Pacific.
The acquisition strengthens S&P Global's infrastructure intelligence capabilities at a time when data center demand from AI workloads, cloud migration, and edge computing is driving unprecedented construction activity. For Turkish companies evaluating U.S. data center investments or colocation arrangements, DataCenterHawk's integration into S&P Global's broader market data ecosystem will make capacity and pricing intelligence more accessible through existing S&P data subscriptions.
Warburg Pincus completes PantherX Rare acquisition
Warburg Pincus completed its acquisition of PantherX Rare, a specialty pharmacy focused on rare disease therapies, on September 8. PantherX serves patients with rare and ultra-rare conditions through a hub-and-spoke distribution model that combines centralized pharmacy services with patient support programs.
Specialty pharmacy acquisitions in the rare disease space involve complex payer contracting, patient assistance program obligations, and FDA-mandated REMS (Risk Evaluation and Mitigation Strategy) compliance requirements. The hub-and-spoke model also creates state pharmacy licensing obligations in each state where PantherX dispenses. Post-closing integration should prioritize continuity of patient services, payer contract assignment, and REMS program compliance to avoid any disruption to patient access.
Key takeaway
The Point72–HubX transaction is the most significant Turkish-origin technology deal of the current review period and illustrates the growing interest of U.S. financial services investors in Turkish B2B software platforms. The cross-border data, regulatory, and CFIUS considerations are material and should be addressed in the transaction documentation and pre-closing regulatory review.
This publication is for general informational purposes only and does not constitute legal advice.
Explore Topics
Written by
Muhammet Halil Ucar
ULF New York legal team — New York-based attorneys advising Turkish companies and investors on U.S. market entry, corporate law, real estate, and international trade.